Raffella Pharmaceuticals

#31 – Navdeep Chandel, Ph.D.: metabolism, mitochondria, and metformin in health and disease

Peter Attia MD

A pharmaceutical company developing a drug that targets alpha-ketoglutarate, an enzyme in the TCA cycle, for pancreatic cancer therapy.